IE
REVB icon

Israel Englander’s Revelation Biosciences REVB Stock Holding History

Israel Englander’s Portfolio REVB Stock Details REVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Hold
0
– -$13K – 6958
2022
Q3 		– Hold
0
– – – 6583
2021
Q4 		– Sell
-1
Closed -$2.99M – 7292
2021
Q3 		$2.99M Hold
1
– – ﹤0.01% 3449
2021
Q2 		$2.71M Hold
1
– – ﹤0.01% 3578
2021
Q1 		$2.62M Buy
+1
New +$2.05M ﹤0.01% 3270

Other funds holding REVB

Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
R
Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
MFA
Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Israel Englander's REVB Position: Q4 2022 in Review

Israel Englander held its Revelation Biosciences (REVB) position steady in Q4 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #6958.

Israel Englander first reported a position in REVB in Q1 2021 and has held it in 3 quarters since. The position peaked at $2.99M in Q3 2021. 2 funds tracked by Wall St. Rank hold REVB as of Q4 2022.

  • Israel Englander held 0 shares of Revelation Biosciences worth $0 as of Q4 2022.
  • Israel Englander left its Revelation Biosciences share count unchanged in Q4 2022.
  • Revelation Biosciences made up ﹤0.01% of Israel Englander's portfolio in Q4 2022, its #6958 holding.
  • Israel Englander first reported a position in Revelation Biosciences in Q1 2021 and has held it in 3 quarters since.
  • Israel Englander's Revelation Biosciences position peaked at $2.99M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Revelation Biosciences as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.